Get a Semaglutide Prescription Today: Same-Day Online Consultation
You can complete Trimi's semaglutide consultation in under 15 minutes, get a physician's decision within 24 hours, and have medication in your hands within a week. Here is exactly how the process works.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This guide covers exactly how Trimi's online semaglutide consultation works, what you need to provide, and how fast you can go from starting the process to having medication in hand.
Quick links: Start your semaglutide consultation, how telehealth prescriptions work, and quick-start guide.
More on Getting Started with GLP-1 Treatment
Semaglutide Without a Doctor Visit
How telehealth prescriptions work and why they are medically valid.
Start Semaglutide This Week
From signup to first injection — the complete quick-start guide.
Ozempic Alternative for $99/Month
Why compounded semaglutide is the same molecule at a fraction of the cost.
Weight Loss Shots for $99/Month
How telehealth made GLP-1 injections affordable.
Why Getting a Semaglutide Prescription Used to Take Weeks
The traditional pathway to a semaglutide prescription involved scheduling an appointment with a primary care physician or obesity specialist — often a wait of two to four weeks. The appointment itself consumed 30 to 60 minutes, including time in a waiting room, vital signs, a conversation about weight history, and potentially lab orders before the provider would prescribe.
Then came insurance. If your plan required prior authorization for Ozempic or Wegovy — and most do — the authorization process could take another two to four weeks. Step therapy requirements might require trying and failing another medication first, adding months. Coverage denials could arrive after all of this, sending patients back to square one.
From deciding to try semaglutide to holding a pen in your hand, the traditional pathway often took six to twelve weeks — and still required paying hundreds of dollars per month if insurance came through, or over $900 per month if it did not.
Trimi's telehealth model eliminates the scheduling delays, the waiting room time, the prior authorization bureaucracy, and the insurance dependency. From deciding today to having your prescription approved: 24 to 48 hours. From approval to medication in hand: 5 to 7 more business days. Total time from starting the process to first dose: typically 10 to 14 days.
How Trimi's Online Consultation Works
Trimi's consultation is an asynchronous telehealth model. There is no live video call, no scheduled appointment time, and no travel required. Here is the exact process:
Phase 1 — The Health Assessment (10–15 minutes)
- Create your Trimi account at trytrimi.com
- Enter your height, current weight, and age
- Answer questions about your medical history — any chronic conditions, prior surgeries, and relevant family history
- List all current medications, including supplements and over-the-counter drugs
- Describe your weight history — previous diets attempted, any prior GLP-1 use, and what prompted you to seek medical weight loss treatment
- Indicate your weight loss goals and any medical conditions you hope treatment will improve
- Confirm you understand the consent and telehealth terms
Phase 2 — Physician Review (within 24 hours, business days)
- A board-certified Trimi physician reviews your complete submission
- They assess clinical eligibility based on BMI (30+ or 27+ with comorbidity), absence of contraindications, and appropriateness of semaglutide versus tirzepatide
- If eligible, they write a prescription for compounded semaglutide at the standard starting dose (0.25mg/week)
- If additional information is needed, they may send a follow-up question through the platform
- You receive a notification of the outcome — approval and prescription, or a note explaining why treatment was not prescribed
Phase 3 — Pharmacy and Shipping (5–7 business days after approval)
- Your prescription is transmitted to Trimi's partner compounding pharmacy
- The pharmacy prepares your compounded semaglutide at the prescribed dose and concentration
- Your order is packaged with injection supplies: insulin syringes, alcohol prep pads, a sharps disposal container, and injection instructions
- The package ships via temperature-controlled carrier with tracking
- You receive a shipping notification with your tracking number
What You Need to Know Before Starting the Assessment
Having the following information ready makes the assessment faster and more accurate:
Have on hand:
- Your current weight (a home scale reading is fine)
- Your height
- A list of current prescription medications with doses
- Any relevant medical conditions (especially pancreatitis, thyroid cancer history, MEN2)
- Prior GLP-1 experience, if any, including which medication and dose
- Your email address for account creation and updates
You do NOT need:
- Insurance information or insurance card
- Lab results or blood work
- A referral from another physician
- Medical records from previous providers
- A prior authorization number
- A pharmacy in your network
Who Gets Approved and Who Does Not
Trimi's providers apply the same standard clinical criteria used in the clinical trials and by obesity medicine specialists for GLP-1 prescriptions. Being transparent about this helps set accurate expectations:
Typically approved:
- BMI 30 or higher with no contraindications
- BMI 27 to 29.9 with type 2 diabetes, prediabetes, hypertension, high cholesterol, or sleep apnea
- Patients who have tried diet/exercise without sufficient results
- Patients currently on Ozempic or Wegovy who want to switch to reduce costs
Typically not approved:
- BMI below 27 without qualifying comorbidities
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia type 2 (MEN2)
- Current pregnancy or active breastfeeding
- History of acute pancreatitis
The GLP-1 candidate eligibility guide covers these criteria in more detail, including how borderline BMI situations are typically evaluated and what role comorbidities play in the decision.
After Approval: What the First Month Looks Like
Once your prescription is approved and your medication arrives, here is what the first month of treatment looks like:
Your first dose arrives. Inject 0.25mg subcutaneously on your scheduled injection day. You may notice subtle appetite suppression early — or it may take a few weeks to become noticeable. Side effects are typically minimal at this starting dose.
Second injection at 0.25mg. Some patients start noticing reduced hunger or earlier satiety. Your body is adjusting to the medication. Continue eating regular meals — do not restrict calories aggressively at this stage.
Continue at 0.25mg. By the end of month one, many patients notice measurable appetite suppression. The standard protocol holds the dose at 0.25mg for the first four weeks specifically to let your system adjust before escalating.
Your dose escalates to 0.5mg at week 5. Your second month's shipment arrives automatically with the new dose. Most patients begin noticing more significant appetite suppression and early weight loss results by weeks 4 to 8.
For the full month-by-month breakdown including dose escalation schedule and what to expect at each stage, see our comprehensive quick-start guide to getting your first dose.
Is a Telehealth Prescription as Legitimate as an In-Person One?
Yes. A prescription written by a board-certified physician following a telehealth consultation is legally equivalent to one written after an in-person appointment. Telehealth prescribing is regulated by state medical boards and is specifically authorized for consultations that do not require a physical examination to assess the patient's condition appropriately.
For GLP-1 weight loss medications, the clinical assessment does not require a physical examination in the traditional sense. The relevant clinical information — BMI, medical history, current medications, contraindications — can be collected accurately through a structured questionnaire. The physician's clinical judgment is applied to that information.
This is why telehealth prescribing for GLP-1 medications has become widely accepted by state medical boards. For a deeper look at the regulatory framework governing telehealth prescriptions and what makes them valid, see our guide to getting semaglutide without an in-person doctor visit.
Trimi providers are licensed physicians
Every Trimi prescription is written by a board-certified physician licensed in the patient's state of residence. Provider credentials are available on the Trimi platform and verified through state medical board records.
Frequently Asked Questions
Can I get a semaglutide prescription the same day?
You can complete Trimi's health assessment and submit your consultation the same day you decide to start — the assessment takes 10 to 15 minutes. Physician review typically occurs within 24 hours on business days. So while the prescription itself may not be written in the same hour you submit, you can go from zero to an approved prescription within 24 to 48 hours of starting the process. Medication then ships within 5 to 7 business days.
Do I need to see a doctor in person to get a semaglutide prescription?
No. Trimi's entire consultation process is online and asynchronous — there is no video call required and no in-person appointment needed. You answer a structured health assessment questionnaire, and a board-certified physician reviews your submission and prescribes if you qualify. This telehealth model is legal, medically valid, and recognized across all 50 states for this type of prescription.
What do I need to provide for the consultation?
You need to provide: your current weight and height (or BMI), a list of current medications, your relevant medical history (particularly any conditions that might be contraindications — pancreatitis, thyroid conditions, MEN2), any prior GLP-1 experience, and your weight loss goals. You do not need to provide lab results, insurance information, or records from previous providers for the initial consultation.
What disqualifies someone from getting a semaglutide prescription?
The main contraindications to semaglutide are: personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia type 2 (MEN2), current pregnancy or breastfeeding, and history of severe pancreatitis. Certain gastrointestinal conditions may also be relevant. Additionally, patients with BMI below 27 (without qualifying comorbidities) or below 30 (without any comorbidities) typically do not meet clinical eligibility criteria. Your Trimi provider evaluates all of these factors.
How much does the Trimi consultation cost?
The consultation is included in the $99 monthly subscription for compounded semaglutide (or $125 for tirzepatide). There is no separate consultation fee. If you are not approved for treatment, Trimi's refund policy ensures you are not charged for medication you did not receive. The $99 is the total all-inclusive monthly price covering medication, provider access, and shipping.
Can I get a semaglutide prescription if I have been denied by my insurance?
Yes. Insurance decisions do not affect Trimi's prescription process at all. Trimi's compounded semaglutide program operates independently of insurance. There is no prior authorization, no formulary review, and no coverage requirement. Insurance denials for Ozempic or Wegovy are completely irrelevant to your Trimi consultation — eligibility is determined solely by your medical history and clinical criteria.
What happens after I get my prescription?
Once your Trimi provider approves your prescription, it is sent to a partner compounding pharmacy. The pharmacy prepares your compounded semaglutide, packages it with injection supplies (syringes, alcohol swabs, a sharps container), and ships it via tracked, temperature-controlled shipping to your address. You typically receive your medication within 5 to 7 business days of approval. Refills ship automatically each month.
Sources & References
- Wilding JPH et al. STEP 1: Once-weekly semaglutide for weight management. NEJM, 2021.
- FDA: Compounding and FDA — Questions and Answers.
- NABP compounding pharmacy accreditation standards.
- AMA: Telehealth policy and practice guidance.
- NIDDK: Prescription medications for overweight and obesity.
- Wegovy FDA prescribing information, 2023.
- Ozempic FDA prescribing information, 2023.
- FDA drug shortage database.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always be truthful and complete in any health assessment you submit — inaccurate information can result in inappropriate prescribing decisions. Telehealth providers rely on patient-reported information and cannot substitute for a comprehensive in-person examination in all circumstances.